N
NeoPharm Co Ltd
KOSDAQ:092730
NeoPharm Co Ltd
KOSDAQ:092730
Price:
29 550 KRW
-0.51%
Market Closed
Updated:
Jun 8, 2024
NeoPharm Co Ltd
Cash from Operating Activities
|
NeoPharm Co Ltd
Cash from Operating Activities Peer Comparison
Comparables:
090430
002790
192820
051900
161890
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
Cash from Operating Activities
₩20.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
20%
|
|
|
AmorePacific Corp
KRX:090430
|
Cash from Operating Activities
₩381.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
|
Amorepacific Group
KRX:002790
|
Cash from Operating Activities
₩422.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-3%
|
|
|
Cosmax Inc
KRX:192820
|
Cash from Operating Activities
₩184.5B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
LG H&H Co Ltd
KRX:051900
|
Cash from Operating Activities
₩668.5B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
6%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Cash from Operating Activities
₩128.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
22%
|
CAGR 10-Years
16%
|
See Also
What is NeoPharm Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
20.1B
KRW
20.1B
KRW
Based on the financial report for Mar 31, 2024, NeoPharm Co Ltd's Cash from Operating Activities amounts to 20.1B KRW.
What is NeoPharm Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
20%
20%
Over the last year, the Cash from Operating Activities growth was 2%. The average annual Cash from Operating Activities growth rates for NeoPharm Co Ltd have been 1% over the past three years , 11% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet
